课题基金 / 基金详情

Identifying oligodendrocyte enhancers that govern the expression of Olig1/2

Identifying oligodendrocyte enhancers that govern the expression of Olig1/2
鉴定控制 Olig1/2 表达的少突胶质细胞增强子
批准号:
9805796
负责人:
YUNGKI PARK
金额:
$43.86万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-07-01 至 2022-06-30

项目摘要

项目成果

YUNGKI PARK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Myelination of the central nervous system (CNS) by oligodendrocytes (OLs) is essential for the development and function of the CNS. Genetic studies have shown that Olig1/2, basic helix-loop-helix transcription factors, are master regulators of OL lineage cells, playing an indispensable role in the development and regeneration of CNS myelin. A fundamental yet unresolved issue surrounding Olig1/2 is who regulates their expression. Apparently, for proper OL development, they have to be expressed at the right level at the right moment in OL lineage cells. What regulatory mechanism ensures it? The first critical step toward this grand challenge is to identify OL enhancers that govern their expression. Historically, finding enhancers for a gene has been difficult. To make a breakthrough for this fundamental issue, we have developed a novel method that takes advantage of recent advances in our understanding of genome organization and enhancers. We have demonstrated its power by applying it to Myrf, uncovering two OL enhancers, including one novel one, that jointly regulate Myrf expression for timely differentiation of OLs. This grant will capitalize on this new powerful method in order to identify OL enhancers that govern the expression of Olig2 (Aim I) and Olig1 (Aim II). .
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Pacs2 in central nervous system myelination
Transcription mechanism of Myrf for central nervous system myelination
Transcription mechanism of Myrf for central nervous system myelination
Transcription mechanism of Myrf for central nervous system myelination
海外基金